Shemesh Rachel, Sandler Hunter, Dichter Sarah, Fabian Ido Didi, Mezer Eedy, Wygnanski-Jaffe Tamara
Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 6997801, Israel.
Sheba Medical Center, Goldschleger Eye Institute, Tel-Hashomer, Ramat Gan 52621, Israel.
Vision (Basel). 2023 Apr 4;7(2):33. doi: 10.3390/vision7020033.
To summarize the characteristics and trends of interest in retinoblastoma (Rb) in the last 50 years.
The Web of Science Database was used to find all studies focused on Rb published from 1970 to 2018. The term "retinoblastoma" was used to search for the 100 most cited records.
The mean number of citations was 153.55 ± 88.9. The majority were from the United States (US) ( = 68). Drs. Shields authored 38% of the papers. The number of citations per year was positively correlated with the number of authors, r = 0.26 ( = 0.008). The number of patients was significantly associated with the number of citations per year ( = 0.012). Although papers on radiotherapy were the most common, publications about intra-arterial chemotherapy (IAC) were associated with 88.3% more citations per year ( = 0.031) and papers on intravenous chemotherapy (IVC) were associated with 40.3% more citations per year (= 0.04). Review and meta-analysis studies had a higher median of citations (10.5) than interventional (6.4) or observational (5.2) studies.
This study compiles a comprehensive analysis of the most-cited articles on Rb. Studies with a higher number of citations per year were associated with IAC, which emphasizes the significance of the advances in Rb treatments that allow for the saving of eyes and vision as well as lives. Review studies had more citations than observational or interventional studies. More citations were associated with a larger number of authors or more reported patients per paper. These findings highlight the importance of collaborations to achieve relevant, high-quality research of Rb.
总结过去50年视网膜母细胞瘤（Rb）研究的特点和趋势。
使用科学网数据库查找1970年至2018年发表的所有聚焦于Rb的研究。使用“视网膜母细胞瘤”一词搜索被引用次数最多的100条记录。
平均被引用次数为153.55±88.9。大多数来自美国（68篇）。希尔兹博士等人撰写了38%的论文。每年的被引用次数与作者数量呈正相关，r = 0.26（P = 0.008）。患者数量与每年的被引用次数显著相关（P = 0.012）。虽然关于放射治疗的论文最为常见，但关于动脉内化疗（IAC）的出版物每年的被引用次数多88.3%（P = 0.031），关于静脉化疗（IVC）的论文每年的被引用次数多40.3%（P = 0.04）。综述和荟萃分析研究的被引用次数中位数（10.5）高于干预性研究（6.4）或观察性研究（5.2）。
本研究对Rb领域被引用次数最多的文章进行了全面分析。每年被引用次数较高的研究与IAC相关，这强调了Rb治疗进展的重要性，这些进展能够挽救眼睛、视力以及生命。综述研究的被引用次数多于观察性或干预性研究。更多的被引用次数与更多的作者数量或每篇论文报告的更多患者数量相关。这些发现凸显了合作对于开展相关高质量Rb研究的重要性。
Zotero 插件